Nibedita Bandyopadhyay

Bayesian Modeling of Recurrent Event Data with Dependent Censoring

Ananda Sen, Nibedita Bandyopadhyay, 2010, Commun. Stat. Simul. Comput..

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Nibedita Bandyopadhyay, Martin Dreyling, Mathias Witzens-Harig, 2016, The Lancet.

Implementation of an adaptive group sequential design in a bioequivalence study.

Vladimir Dragalin, Nibedita Bandyopadhyay, 2007, Pharmaceutical statistics.